Related references
Note: Only part of the references are listed.Imaging SERT Availability in a Rat Model of L-DOPA-Induced Dyskinesia
Michael Walker et al.
MOLECULAR IMAGING AND BIOLOGY (2020)
Dyskinesia matters
M. Angela Cenci et al.
MOVEMENT DISORDERS (2020)
6-Hydroxydopamine lesion and levodopa treatment modify the effect of buspirone in thesubstantia nigra pars reticulata
Sergio Vegas-Suarez et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Frequency-Specific Optogenetic Deep Brain Stimulation of Subthalamic Nucleus Improves Parkinsonian Motor Behaviors
Chunxiu Yu et al.
JOURNAL OF NEUROSCIENCE (2020)
ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020
Elliott Lilley et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
Nathalie Percie du Sert et al.
PLOS BIOLOGY (2020)
Circuit Mechanisms of Parkinson's Disease
Matthew M. McGregor et al.
NEURON (2019)
CLINICAL TRIAL HIGHLIGHTS ? DYSKINESIA
Kevin McFarthing et al.
JOURNAL OF PARKINSONS DISEASE (2019)
Molecular and anatomical organization of the dorsal raphe nucleus
Kee Wui Huang et al.
ELIFE (2019)
Acute L-DOPA administration reverses changes in firing pattern and low frequency oscillatory activity in the entopeduncular nucleus from long term L-DOPA treated 6-OHDA-lesioned rats
A. Aristieta et al.
EXPERIMENTAL NEUROLOGY (2019)
Activation of the subthalamic nucleus suppressed by high frequency stimulation: A c-Fos immunohistochemical study
Safa Shehab et al.
BRAIN RESEARCH (2018)
Dopamine receptors in the rat entopeduncular nucleus
Hagar Lavian et al.
BRAIN STRUCTURE & FUNCTION (2018)
Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology
Steve P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers
Michael J. Curtis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Globus Pallidus Interna or Subthalamic Nucleus Deep Brain Stimulation for Parkinson Disease A Review
Adolfo Ramirez-Zamora et al.
JAMA NEUROLOGY (2018)
BDNF over-expression induces striatal serotonin fiber sprouting and increases the susceptibility to L-DOPA-induced dyskinesia in 6-OHDA-lesioned rats
Elisabetta Tronci et al.
EXPERIMENTAL NEUROLOGY (2017)
Epidemiology of Parkinson's disease
Ole-Bjorn Tysnes et al.
JOURNAL OF NEURAL TRANSMISSION (2017)
Dopaminergic Modulation of Synaptic Integration and Firing Patterns in the Rat Entopeduncular Nucleus
Hagar Lavian et al.
JOURNAL OF NEUROSCIENCE (2017)
Buspirone requires the intact nigrostriatal pathway to reduce the activity of the subthalamic nucleus via 5-HT1A receptors
A. Sagarduy et al.
EXPERIMENTAL NEUROLOGY (2016)
Neuronal Entropy-Rate Feature of Entopeduncular Nucleus in Rat Model of Parkinson's Disease
Olivier Darbin et al.
INTERNATIONAL JOURNAL OF NEURAL SYSTEMS (2016)
Coherence of neuronal firing of the entopeduncular nucleus with motor cortex oscillatory activity in the 6-OHDA rat model of Parkinson's disease with levodopa-induced dyskinesias
Xingxing Jin et al.
EXPERIMENTAL BRAIN RESEARCH (2016)
Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients
Marios Politis et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
SEROTONERGIC NERVE FIBERS IN L-DOPA-DERIVED DOPAMINE RELEASE AND DYSKINESIA
N. Nevalainen et al.
NEUROSCIENCE (2014)
Modulation of the subthalamic nucleus activity by serotonergic agents and fluoxetine administration
A. Aristieta et al.
PSYCHOPHARMACOLOGY (2014)
Interaction between the 5-HT system and the basal ganglia: functional implication and therapeutic perspective in Parkinson's disease
Cristina Miguelez et al.
FRONTIERS IN NEURAL CIRCUITS (2014)
Cell type-specific and time-dependent light exposure contribute to silencing in neurons expressing Channelrhodopsin-2
Alexander M. Herman et al.
ELIFE (2014)
Chronic L-Dopa Decreases Serotonin Neurons in a Subregion of the Dorsal Raphe Nucleus
Branden J. Stansley et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Increased excitability in serotonin neurons in the dorsal raphe nucleus in the 6-OHDA mouse model of Parkinson's disease
Alexander Prinz et al.
EXPERIMENTAL NEUROLOGY (2013)
Modification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptors
Jack Bergman et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Role of Serotonergic 1A Receptor Dysfunction in Depression Associated with Parkinson's Disease
Benedicte Ballanger et al.
MOVEMENT DISORDERS (2012)
Increased levels of 5-HT1A receptor binding in ventral visual pathways in Parkinson's disease
Philippe Huot et al.
MOVEMENT DISORDERS (2012)
Unilateral lesion of the nigrostriatal pathway decreases the response of GABA interneurons in the dorsal raphe nucleus to 5-HT1A receptor stimulation in the rat
C. Hou et al.
NEUROCHEMISTRY INTERNATIONAL (2012)
The Role of the Subthalamic Nucleus in L-DOPA Induced Dyskinesia in 6-Hydroxydopamine Lesioned Rats
Asier Aristieta et al.
PLOS ONE (2012)
A user's guide to channelrhodopsin variants: features, limitations and future developments
John Y. Lin
EXPERIMENTAL PHYSIOLOGY (2011)
Gender effect on time to levodopa-induced dyskinesias
Sharon Hassin-Baer et al.
JOURNAL OF NEUROLOGY (2011)
The locus coeruleus Is Directly Implicated in L-DOPA-Induced Dyskinesia in Parkinsonian Rats: An Electrophysiological and Behavioural Study
Cristina Miguelez et al.
PLOS ONE (2011)
Maladaptive Plasticity of Serotonin Axon Terminals in Levodopa-Induced Dyskinesia
Daniella Rylander et al.
ANNALS OF NEUROLOGY (2010)
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Carol Kilkenny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Characterization of Engineered Channel rhodopsin Variants with Improved Properties and Kinetics
John Y. Lin et al.
BIOPHYSICAL JOURNAL (2009)
Different functional basal ganglia subcircuits associated with anti-akinetic and dyskinesiogenic effects of antiparkinsonian therapies
Emilie Lacombe et al.
NEUROBIOLOGY OF DISEASE (2009)
Serotonergic modulation of basal ganglia circuits Complexity and therapeutic opportunities
Eduardo E. Benarroch
NEUROLOGY (2009)
Spared caudal brainstem SERT binding in early Parkinson's disease
Roger L. Albin et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2008)
Inhibition of 5-HT neuron activity and induction of depressive-like behavior by high-frequency stimulation of the subthalamic nucleus
Yasin Temel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The partial 5-HT1A agonist buspirone reduces the expression and development of I-DOPA-induced dyskinesia in rats and improves I-DOPA efficacy
Karen L. Eskow et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2007)
The differential effects of 5-HT1A receptor stimulation on dopamine receptor-mediated abnormal involuntary movements and rotations in the primed herniparkinsonian rat
Kristin B. Dupre et al.
BRAIN RESEARCH (2007)
Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat
S. Breit et al.
EXPERIMENTAL NEUROLOGY (2007)
Modulation of L-DOPA-induced abnormal involuntary movements by clinically tested compounds: Further validation of the rat dyskinesia model
Andrzej Dekundy et al.
BEHAVIOURAL BRAIN RESEARCH (2007)
In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates, the selective 5-hydroxytryptamine 1a agonist (R)-(+)-8-OHDPAT inhibits levodopa-induced dyskinesia but only with\increased motor disability
Mahmoud M. Iravani et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease
F. Alonso-Frech et al.
BRAIN (2006)
MK801 and amantadine exert different effects on subthalamic neuronal activity in a rodent model of Parkinson's disease
KA Allers et al.
EXPERIMENTAL NEUROLOGY (2005)
Effect of subthalamic nucleus or entopeduncular nucleus lesion on levodopa-induced neurochemical changes within the basal ganglia and on levodopa-induced motor alterations in 6-hydroxydopamine-lesioned rats
C Périer et al.
JOURNAL OF NEUROCHEMISTRY (2003)
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease
CW Olanow et al.
ANNALS OF NEUROLOGY (2003)
Idiopathic Parkinson's disease:: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen
H Braak et al.
JOURNAL OF NEURAL TRANSMISSION (2003)
Tremor in Parkinson's disease and serotonergic dysfunction -: An 11C-WAY 100635 PET study
M Doder et al.
NEUROLOGY (2003)
Disruption of the two-state membrane potential of striatal neurones during cortical desynchronisation in anaesthetised rats
F Kasanetz et al.
JOURNAL OF PHYSIOLOGY-LONDON (2002)
Nigrostriatal lesion and dopamine agonists affect firing patterns of rodent entopeduncular nucleus neurons
DN Ruskin et al.
JOURNAL OF NEUROPHYSIOLOGY (2002)
Effects of high frequency stimulation of subthalamic nucleus on extracellular glutamate and GABA in substantia nigra and globus pallidus in the normal rat
F Windels et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)
Share Paper
